148 related articles for article (PubMed ID: 19252387)
21. The strategic relevance of manufacturing technology: An overall quality concept to promote innovation preventing drug shortage.
Panzitta M; Ponti M; Bruno G; Cois G; D'Arpino A; Minghetti P; Mendicino FR; Perioli L; Ricci M
Int J Pharm; 2017 Jan; 516(1-2):144-157. PubMed ID: 27838294
[TBL] [Abstract][Full Text] [Related]
22. Microdosing studies in humans: the role of positron emission tomography.
Bauer M; Wagner CC; Langer O
Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
[TBL] [Abstract][Full Text] [Related]
23. PhRMA survey on the conduct of first-in-human clinical trials under exploratory investigational new drug applications.
Karara AH; Edeki T; McLeod J; Tonelli AP; Wagner JA
J Clin Pharmacol; 2010 Apr; 50(4):380-91. PubMed ID: 20097935
[TBL] [Abstract][Full Text] [Related]
24. Image-driven pharmacokinetics: nanomedicine concentration across space and time.
Brill DA; MacKay JA
Nanomedicine (Lond); 2015; 10(18):2861-79. PubMed ID: 26370694
[TBL] [Abstract][Full Text] [Related]
25. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
26. Molecular imaging with SPECT as a tool for drug development.
Gomes CM; Abrunhosa AJ; Ramos P; Pauwels EK
Adv Drug Deliv Rev; 2011 Jun; 63(7):547-54. PubMed ID: 20933557
[TBL] [Abstract][Full Text] [Related]
27. Translational PET imaging research.
Hargreaves RJ; Rabiner EA
Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
[TBL] [Abstract][Full Text] [Related]
28. Current and emerging imaging in relation to drug discovery in airways disease.
King GG
Pulm Pharmacol Ther; 2011 Oct; 24(5):497-504. PubMed ID: 21807109
[TBL] [Abstract][Full Text] [Related]
29. Has molecular and cellular imaging enhanced drug discovery and drug development?
Niu G; Chen X
Drugs R D; 2008; 9(6):351-68. PubMed ID: 18989988
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography: establishing priorities for health technology assessment.
Robert G; Milne R
Health Technol Assess; 1999; 3(16):1-54. PubMed ID: 10632626
[TBL] [Abstract][Full Text] [Related]
31. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
32. Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening.
Xiao H; Sun M; Zhao R; Hong H; Zhang A; Zhang S; Liu F; Zhang Y; Liu Y; Zhu L; Kung HF; Qiao J
J Pharm Biomed Anal; 2018 May; 154():48-56. PubMed ID: 29533858
[TBL] [Abstract][Full Text] [Related]
33. Clinical positron emission tomography/magnetic resonance imaging applications.
von Schulthess GK; Kuhn FP; Kaufmann P; Veit-Haibach P
Semin Nucl Med; 2013 Jan; 43(1):3-10. PubMed ID: 23178084
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive imaging in experimental medicine for drug development.
Matthews PM; Rabiner I; Gunn R
Curr Opin Pharmacol; 2011 Oct; 11(5):501-7. PubMed ID: 21570913
[TBL] [Abstract][Full Text] [Related]
35. Can positron emission tomography facilitate paediatric drug development?
Zimmer L
Fundam Clin Pharmacol; 2008 Dec; 22(6):595-8. PubMed ID: 19049660
[TBL] [Abstract][Full Text] [Related]
36. Imaging tumour-bearing animals using clinical scanners.
Wolf G; Abolmaali N
Int J Radiat Biol; 2009 Sep; 85(9):752-62. PubMed ID: 19479601
[TBL] [Abstract][Full Text] [Related]
37. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
38. Target engagement in lead generation.
Durham TB; Blanco MJ
Bioorg Med Chem Lett; 2015 Mar; 25(5):998-1008. PubMed ID: 25630223
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
